{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T12:26:21Z","timestamp":1791721581301,"version":"4.3.4"},"reference-count":36,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000738","name":"U.S. Department of Veterans Affairs","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000738","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000069","name":"National Institute of Arthritis and Musculoskeletal and Skin Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000069","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bone"],"published-print":{"date-parts":[[2021,2]]},"DOI":"10.1016\/j.bone.2020.115708","type":"journal-article","created":{"date-parts":[[2020,10,24]],"date-time":"2020-10-24T10:55:47Z","timestamp":1603536947000},"page":"115708","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"special_numbering":"C","title":["Co-deletion of Lrp5 and Lrp6 in the skeleton severely diminishes bone gain from sclerostin antibody administration"],"prefix":"10.1016","volume":"143","author":[{"given":"Kyung-Eun","family":"Lim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Whitney A.","family":"Bullock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel J.","family":"Horan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bart O.","family":"Williams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew L.","family":"Warman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander G.","family":"Robling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bone.2020.115708_bb0005","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1007\/978-981-13-3681-2_16","article-title":"Osteoporosis and the ageing skeleton","volume":"91","author":"Aspray","year":"2019","journal-title":"Subcell. Biochem."},{"key":"10.1016\/j.bone.2020.115708_bb0010","author":"Foundation NO"},{"issue":"7","key":"10.1016\/j.bone.2020.115708_bb0015","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1001\/jama.2016.11136","article-title":"Effect of abaloparatide vs Placebo on New Vertebral Fractures in Postmenopausal Women With Osteoporosis: A Randomized Clinical Trial","volume":"316","author":"Miller","year":"2016","journal-title":"JAMA"},{"issue":"15","key":"10.1016\/j.bone.2020.115708_bb0020","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1056\/NEJMoa1708322","article-title":"Romosozumab or Alendronate for Fracture Prevention in Women with Osteoporosis","volume":"377","author":"Saag","year":"2017","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.bone.2020.115708_bb0025","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1086\/318811","article-title":"Bone dysplasia sclerosteosis results from loss of the SOST gene product, a novel cystine knot-containing protein","volume":"68","author":"Brunkow","year":"2001","journal-title":"Am J Hum Genet"},{"issue":"5","key":"10.1016\/j.bone.2020.115708_bb0030","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1093\/hmg\/10.5.537","article-title":"Increased bone density in sclerosteosis is due to the deficiency of a novel secreted protein (SOST)","volume":"10","author":"Balemans","year":"2001","journal-title":"Hum Mol Genet"},{"issue":"20","key":"10.1016\/j.bone.2020.115708_bb0035","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1056\/NEJMoa013444","article-title":"High bone density due to a mutation in LDL-receptor-related protein 5","volume":"346","author":"Boyden","year":"2002","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.bone.2020.115708_bb0040","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1086\/338450","article-title":"A mutation in the LDL receptor-related protein 5 gene results in the autosomal dominant high-bone-mass trait","volume":"70","author":"Little","year":"2002","journal-title":"Am J Hum Genet"},{"issue":"50","key":"10.1016\/j.bone.2020.115708_bb0045","doi-asserted-by":"crossref","first-page":"38276","DOI":"10.1074\/jbc.M609509200","article-title":"LRP5 mutations linked to high bone mass diseases cause reduced LRP5 binding and inhibition by SOST","volume":"281","author":"Semenov","year":"2006","journal-title":"J. Biol. Chem."},{"issue":"29","key":"10.1016\/j.bone.2020.115708_bb0050","doi-asserted-by":"crossref","first-page":"26770","DOI":"10.1074\/jbc.M504308200","article-title":"SOST is a ligand for LRP5\/LRP6 and a Wnt signaling inhibitor","volume":"280","author":"Semenov","year":"2005","journal-title":"J. Biol. Chem."},{"issue":"6","key":"10.1016\/j.bone.2020.115708_bb0055","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1038\/nm.2388","article-title":"Lrp5 functions in bone to regulate bone mass","volume":"17","author":"Cui","year":"2011","journal-title":"Nat Med"},{"issue":"6","key":"10.1016\/j.bone.2020.115708_bb0060","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1359\/jbmr.080216","article-title":"Targeted deletion of the sclerostin gene in mice results in increased bone formation and bone strength","volume":"23","author":"Li","year":"2008","journal-title":"J Bone Miner Res"},{"issue":"5","key":"10.1016\/j.bone.2020.115708_bb0065","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1016\/j.bone.2011.07.034","article-title":"High-bone-mass-producing mutations in the Wnt signaling pathway result in distinct skeletal phenotypes","volume":"49","author":"Niziolek","year":"2011","journal-title":"Bone"},{"issue":"8","key":"10.1016\/j.bone.2020.115708_bb0070","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1002\/jbmr.376","article-title":"Levels of serotonin, sclerostin, bone turnover markers as well as bone density and microarchitecture in patients with high-bone-mass phenotype due to a mutation in Lrp5","volume":"26","author":"Frost","year":"2011","journal-title":"J Bone Miner Res"},{"issue":"12","key":"10.1016\/j.bone.2020.115708_bb0075","doi-asserted-by":"crossref","first-page":"2033","DOI":"10.1359\/jbmr.040907","article-title":"Decreased BMD and limb deformities in mice carrying mutations in both Lrp5 and Lrp6","volume":"19","author":"Holmen","year":"2004","journal-title":"J Bone Miner Res"},{"issue":"10","key":"10.1016\/j.bone.2020.115708_bb0080","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1359\/jbmr.080512","article-title":"Lrp6 hypomorphic mutation affects bone mass through bone resorption in mice and impairs interaction with Mesd","volume":"23","author":"Kubota","year":"2008","journal-title":"J Bone Miner Res"},{"issue":"211","key":"10.1016\/j.bone.2020.115708_bb0085","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3006627","article-title":"Sclerostin inhibition reverses skeletal fragility in an Lrp5-deficient mouse model of OPPG syndrome","volume":"5","author":"Kedlaya","year":"2013","journal-title":"Sci Transl Med"},{"issue":"8","key":"10.1016\/j.bone.2020.115708_bb0090","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0023537","article-title":"Dissecting molecular differences between Wnt coreceptors LRP5 and LRP6","volume":"6","author":"MacDonald","year":"2011","journal-title":"PLoS One"},{"issue":"20","key":"10.1016\/j.bone.2020.115708_bb0095","doi-asserted-by":"crossref","first-page":"19883","DOI":"10.1074\/jbc.M413274200","article-title":"Sclerostin binds to LRP5\/6 and antagonizes canonical Wnt signaling","volume":"280","author":"Li","year":"2005","journal-title":"J Biol Chem"},{"issue":"32","key":"10.1016\/j.bone.2020.115708_bb0100","doi-asserted-by":"crossref","first-page":"26464","DOI":"10.1074\/jbc.M112.350108","article-title":"Characterization of the interaction of sclerostin with the low density lipoprotein receptor-related protein (LRP) family of Wnt co-receptors","volume":"287","author":"Holdsworth","year":"2012","journal-title":"J Biol Chem"},{"issue":"23","key":"10.1016\/j.bone.2020.115708_bb0105","doi-asserted-by":"crossref","first-page":"6267","DOI":"10.1093\/emboj\/cdg599","article-title":"Osteocyte control of bone formation via sclerostin, a novel BMP antagonist","volume":"22","author":"Winkler","year":"2003","journal-title":"EMBO J"},{"issue":"1","key":"10.1016\/j.bone.2020.115708_bb0110","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.bbrc.2009.12.143","article-title":"Sclerostin binds and regulates the activity of cysteine-rich protein 61","volume":"392","author":"Craig","year":"2010","journal-title":"Biochem Biophys Res Commun"},{"issue":"2","key":"10.1016\/j.bone.2020.115708_bb0115","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1016\/j.bbrc.2011.12.048","article-title":"The sclerostin-bone protein interactome","volume":"417","author":"Devarajan-Ketha","year":"2012","journal-title":"Biochem Biophys Res Commun"},{"issue":"2","key":"10.1016\/j.bone.2020.115708_bb0120","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.bbrc.2010.10.048","article-title":"Sclerostin-erbB-3 interactions: modulation of erbB-3 activity by sclerostin","volume":"402","author":"Craig","year":"2010","journal-title":"Biochem Biophys Res Commun"},{"issue":"2","key":"10.1016\/j.bone.2020.115708_bb0125","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.ydbio.2011.08.020","article-title":"Lrp5 and Lrp6 redundantly control skeletal development in the mouse embryo","volume":"359","author":"Joeng","year":"2011","journal-title":"Dev Biol"},{"issue":"4","key":"10.1016\/j.bone.2020.115708_bb0130","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1177\/154405910708600404","article-title":"DMP1-targeted Cre expression in odontoblasts and osteocytes","volume":"86","author":"Lu","year":"2007","journal-title":"J. Dent. Res."},{"issue":"4","key":"10.1016\/j.bone.2020.115708_bb0135","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1359\/jbmr.081206","article-title":"Sclerostin antibody treatment increases bone formation, bone mass, and bone strength in a rat model of postmenopausal osteoporosis","volume":"24","author":"Li","year":"2009","journal-title":"J Bone Miner Res"},{"issue":"7","key":"10.1016\/j.bone.2020.115708_bb0140","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1002\/jbmr.141","article-title":"Guidelines for assessment of bone microstructure in rodents using micro-computed tomography","volume":"25","author":"Bouxsein","year":"2010","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2020.115708_bb0145","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.bone.2016.09.001","article-title":"Sost, independent of the non-coding enhancer ECR5, is required for bone mechanoadaptation","volume":"92","author":"Robling","year":"2016","journal-title":"Bone"},{"issue":"8","key":"10.1016\/j.bone.2020.115708_bb0150","doi-asserted-by":"crossref","first-page":"2963","DOI":"10.1210\/en.2011-0049","article-title":"Anabolic and catabolic regimens of human parathyroid hormone 1-34 elicit bone- and envelope-specific attenuation of skeletal effects in Sost-deficient mice","volume":"152","author":"Robling","year":"2011","journal-title":"Endocrinology"},{"issue":"1","key":"10.1016\/j.bone.2020.115708_bb0155","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1002\/jbmr.1805","article-title":"Standardized nomenclature, symbols, and units for bone histomorphometry: a 2012 update of the report of the ASBMR Histomorphometry Nomenclature Committee","volume":"28","author":"Dempster","year":"2013","journal-title":"J Bone Miner Res"},{"issue":"8","key":"10.1016\/j.bone.2020.115708_bb0160","doi-asserted-by":"crossref","first-page":"3047","DOI":"10.1210\/en.2015-1587","article-title":"Adult-Onset Deletion of beta-Catenin in (10kb)Dmp1-Expressing Cells Prevents Intermittent PTH-Induced Bone Gain","volume":"157","author":"Kedlaya","year":"2016","journal-title":"Endocrinology"},{"key":"10.1016\/j.bone.2020.115708_bb0165","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.isci.2019.09.023","article-title":"Lrp4 Mediates Bone Homeostasis and mechanotransduction through Interaction with Sclerostin In Vivo","volume":"20","author":"Bullock","year":"2019","journal-title":"iScience"},{"issue":"5","key":"10.1016\/j.bone.2020.115708_bb0170","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0063323","article-title":"Lrp5 and Lrp6 exert overlapping functions in osteoblasts during postnatal bone acquisition","volume":"8","author":"Riddle","year":"2013","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.bone.2020.115708_bb0175","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1002\/jbmr.2059","article-title":"Reversing LRP5-dependent osteoporosis and SOST deficiency-induced sclerosing bone disorders by altering WNT signaling activity","volume":"29","author":"Chang","year":"2014","journal-title":"J Bone Miner Res"},{"issue":"5","key":"10.1016\/j.bone.2020.115708_bb0180","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1002\/jbmr.3038","article-title":"Sclerostin Antibody Administration Converts Bone Lining Cells Into Active Osteoblasts","volume":"32","author":"Kim","year":"2017","journal-title":"J Bone Miner Res"}],"container-title":["Bone"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S8756328220304889?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S8756328220304889?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T17:51:26Z","timestamp":1757613086000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S8756328220304889"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2]]},"references-count":36,"alternative-id":["S8756328220304889"],"URL":"https:\/\/doi.org\/10.1016\/j.bone.2020.115708","relation":{},"ISSN":["8756-3282"],"issn-type":[{"value":"8756-3282","type":"print"}],"subject":[],"published":{"date-parts":[[2021,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Co-deletion of Lrp5 and Lrp6 in the skeleton severely diminishes bone gain from sclerostin antibody administration","name":"articletitle","label":"Article Title"},{"value":"Bone","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bone.2020.115708","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"115708"}}